Predict your next investment

Cognita Labs company logo
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
cognitalabs.com

See what CB Insights has to offer

Founded Year

2013

About Cognita Labs

Cognita Labs develops diagnostic and patient care management for chronic respiratory illnesses, like Asthma and COPD. The company's product CapMedic is an inhaler cap that can measure both correctness and regularity of inhaler use. The company's product PulmoScan is an affordable lung diagnostic device.

Cognita Labs Headquarter Location

700 N Main St C1

Santa Ana, California, 92701,

United States

713-480-7770

Latest Cognita Labs News

World Respiratory Health Management Technology Market Report 2021 Featuring Clin-e-cal, Cognita Labs, Qure AI, ResApp Health Limited, & Zebra Medical Vision - ResearchAndMarkets.com

Aug 17, 2021

This growth opportunity-technology report explores innovations and patents in this space and provides more details about notable companies that are making strides in research and development. It includes explanations about the drivers and restraints that will shape the market through the middle of the decade, and touches on the effects of the COVID-19 pandemic related to the demand for devices and further innovations. Technology licensing should be on the radar for pharmaceutical companies offering drugs for respiratory diseases. They can offer their drugs with an innovative inhaler device. Respiratory diseases are related to the airways and the structures of the lungs. They can affect air sacs, interstitium, blood vessels, pleura, and chest wall. Common respiratory diseases include chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension, and occupational lung disease. According to the World Health Organization, more than 339 million people have asthma globally (it is common in children). COPD is the cause of more than 3 million deaths around the world every year. Problems with accuracy, a lack of user-friendly features, and an inability to provide real-time feedback have restrained the use of mobile applications and smart inhalers for respiratory disease management but created opportunities for companies developing artificial intelligence, machine learning, and other solutions for diagnostic and therapeutic devices. Key Topics Covered: 1.0 Strategic Imperatives 1.2 The Strategic Imperative 1.4 Growth Opportunities Fuel the Growth Pipeline Engine 2.0 Research Context and Key Findings 2.1 Research Scope 2.2 Research Methodology 2.3 Improving Patient Outcomes with Real-time Feedback via Smart Inhalers and Portable and Lightweight Oxygen Concentrators for Increasing Home-Based Therapy is a Key Growth Opportunity 3.0 Market Overview 3.1 The Increasing Burden of Chronic Respiratory Diseases Calls For Innovative Technology that Can Improve Patients' Quality of Life by Enabling Better Management 3.2 A Broad Range of Diagnostic and Therapeutic Medical Devices Are Currently Used That Enable Better Management of Respiratory Diseases 3.3 Growth Drivers 4.2 A Wide Range of Medical Devices Are Used for the Diagnosis of Respiratory Diseases 4.3 Therapeutic Medical Devices are Preferred by Physicians and Patients for Acute and Chronic Respiratory Conditions 5.0 Diagnostic Devices: Mobile Medical Applications 5.1 Mobile Medical Applications Designed for Diagnosis Offer Education and Behavioural Change Motivation to The Patients 5.2 Mobile Medical Applications are a Cost-effective Alternative to Traditional Healthcare with Multiple Benefits 5.3 Mobile Medical Applications Support the Diagnosis of Respiratory Diseases and Increase Patient Engagement 5.4 Most of the Mobile Medical Applications in Clinical Trials are Monitoring Symptoms that can Support Early Disease Diagnosis 5.5 Mobile Medical Applications Offered by the Key Participants are Enabling Continuous Symptom Tracking and Remote Monitoring of the Patient 5.6 Entities Developing Innovative Mobile Medical Applications Should Focus On Must-Have Features along with Other Complementary Features 6.0 Diagnostic Devices: Medical Imaging Software 6.1 Medical Imaging Software Improves Diagnostic Accuracy and Supports Doctors in Designing Better Treatment for Patients 6.2 Medical Imaging Software Enables Early and Accurate Respiratory Disease Diagnosis 6.3 Medical Imaging Software Offered by Key Participants Provides Better Visualization and Enables Improved Image Analysis 6.4 Market Participants Developing New Medical Imaging Software Should Integrate this with AI/ML to Improve its Disease Diagnosis Accuracy 7.0 Therapeutic Devices: Smart Inhalers 7.1 Smart Inhalers Enable High Patient Engagement and Improve Treatment Effectiveness 7.2 Growing Prevalence of Chronic Respiratory Diseases and Push for Digital Technologies are the Key Industry Trends for Smart Inhalers 7.3 Choice of Inhalation Type Depends on its Effectiveness in Certain Diseases, the Patient's Preference, and the Doctor's Recommendation 7.4 Inhaled Vaccines, Cannabis, and Gene Therapy are the Innovative Applications under Research and Clinical Trial 7.5 Technological Innovations are Focusing on Development of Connected Inhaler Devices with Data Tracking Capability that Enable Compliance and Remote Monitoring 7.6 The Smart Technologies Offered by the Key Industry Participants Focus on Tracking the Medication Adherence and Inhaler Usage of the Patient 7.7 Innovative Smart Inhaler Technologies Should Focus on High Patient Engagement and Connectivity for Remote Monitoring of Health Condition 8.0 Therapeutic Devices: Oxygen Concentrators 8.1 Oxygen Concentrators are a Cost-effective Long-Term Solution for Continuous Oxygen Supply to Patients with Respiratory Disease 8.2 Selection of the Oxygen Concentrator Depends on the Patient's Disease Condition, Oxygen Requirements, and its Costs 8.3 The COVID-19 Pandemic is Driving the Demand for Oxygen Concentrators 8.4 Oxygen Concentrators Offered by the Key Industry Participants are Lightweight and Portable to Ensure Patient Comfort During Use 8.5 Innovative Oxygen Concentrators Should Focus on the Development of High Flow Rate and Portability Features 9.0 Companies to Action

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cognita Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cognita Labs is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

10,410 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

Cognita Labs Patents

Cognita Labs has filed 2 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Medical equipment
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/13/2015

3/23/2021

Dosage forms, Drug delivery devices, Routes of administration, Medical equipment, Medical terminology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/13/2015

00/00/0000

Grant Date

3/23/2021

00/00/0000

Title

Subscribe to see more

Related Topics

Dosage forms, Drug delivery devices, Routes of administration, Medical equipment, Medical terminology

Subscribe to see more

Status

Grant

Subscribe to see more

Cognita Labs Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cognita Labs Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.